SCHEMBL7419667

SCHEMBL7419667

CC(=O)CON1Cc2ccccc2CC1=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NOTUM Q6P988 3/20 0.43
▸ RNASEH1 O60930 1/20 0.38
▸ HSD17B3 P37058 1/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ HDAC8 Q9BY41 3/20 0.36
▸ ALOX15 P16050 1/20 0.36
▸ NAMPT P43490 1/20 0.35
▸ MEN1 O00255 3/20 0.35
▸ KMT2A Q03164 3/20 0.35
▸ APAF1 O14727 2/20 0.35
▸ GAA P10253 1/20 0.35
▸ CASP3 P42574 1/20 0.35
▸ SENP8 Q96LD8 1/20 0.35
▸ SENP7 Q9BQF6 1/20 0.35
▸ SENP6 Q9GZR1 1/20 0.35
▸ HSP90AA1 P07900 2/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ HPGD P15428 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7419083 0.82 NR1H2 (0.39) HSD17B3HDAC8NAMPTGAAALDH1A1
SCHEMBL7898985 0.65 RNASEH1 (0.50) NOTUMRNASEH1MEN1KMT2AGAA
SCHEMBL677618 0.65 BRD4 (0.50) NOTUMRNASEH1HPGD
SCHEMBL8966163 0.65 ACHE (0.46) NOTUMRNASEH1HSD17B3NPC1RAB9A
SCHEMBL38662990 0.65 KDM4E (0.54) NOTUMRAB9AALOX15MEN1KMT2A
SCHEMBL12226485 0.64 NOTUM (0.55) NOTUMHSD17B3NPC1RAB9AHDAC8
SCHEMBL8610167 0.64 ALDH1A1 (0.65) MEN1KMT2AGAAALDH1A1MAPT
SCHEMBL7335861 0.64 NOTUM (0.42) NOTUMRNASEH1HSD17B3NPC1RAB9A
SCHEMBL19410673 0.64 NOTUM (0.58) NOTUMMAPTHPGD
Acetone SCHEMBL27589367 0.63 CYP1A2 (0.52) NOTUMHSD17B3NPC1RAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5602145-A Bicyclic fibrinogen antagonists SMITHKLINE BEECHAM CORPORATION (US) 1997-02-11 — — US disclosed
EP-0702671-A4 BICYCLIC FIBRINOGEN ANTAGONISTS SMITHKLINE BEECHAM CORP (US) 1996-06-19 — — EP disclosed
EP-0702671-A1 BICYCLIC FIBRINOGEN ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 1996-03-27 — — EP disclosed
WO-1994029273-A1 BICYCLIC FIBRINOGEN ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 1994-12-22 — — WO disclosed
Send feedback